Correlation Between Pfizer and Castle Biosciences

Can any of the company-specific risk be diversified away by investing in both Pfizer and Castle Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Castle Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Castle Biosciences, you can compare the effects of market volatilities on Pfizer and Castle Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Castle Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Castle Biosciences.

Diversification Opportunities for Pfizer and Castle Biosciences

-0.38

Correlation Coefficient

Pfizer  Castle Biosciences

Very good diversification

The 3 months correlation between Pfizer and Castle is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Castle Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Castle Biosciences and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Castle Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Castle Biosciences has no effect on the direction of Pfizer i.e., Pfizer and Castle Biosciences go up and down completely randomly.

Pair Corralation between Pfizer and Castle Biosciences

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Castle Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 2.94 times less risky than Castle Biosciences. The stock trades about -0.02 of its potential returns per unit of risk. The Castle Biosciences is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  1,985  in Castle Biosciences on July 24, 2024 and sell it today you would earn a total of  1,241  from holding Castle Biosciences or generate 62.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Castle Biosciences

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Castle Biosciences

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Castle Biosciences are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Castle Biosciences disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pfizer and Castle Biosciences

The main advantage of trading using opposite Pfizer and Castle Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Castle Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Castle Biosciences will offset losses from the drop in Castle Biosciences' long position.

The idea behind Pfizer Inc and Castle Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.